Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma

Clinical trial NCT01956084 · COMPLETED

Trial details

NCT number: NCT01956084
Sponsor: Catherine Bollard
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Disease Non Hodgkin Lymphoma Lymphoepithelioma Severe Chronic Active EBV Infection Syndrome (SCAEBV)Leiomyosarcoma

Start date: 2013-11-01
Primary completion: 2017-11-19
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.